Official AMFI data
Arthkar
Bandhan

Bandhan Healthcare Fund

Sectoral / ThematicEquity SEBI-regulated

NAV (Direct-Growth)

₹10.9730

As of 3 Jul 2026 · AMFI

AUM

₹310.92 Cr

Expense ratio

0.74%

1Y returns

cat 12.11%

3Y CAGR

cat 22.73%

5Y CAGR

cat 13.72%

Std deviation 3Y

cat 16.29%

In plain English

Bandhan Healthcare Fund is a Sectoral / Thematic scheme from Bandhan. The portfolio is ~96% in equities. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

Showing Direct · Growth · INF194KB1KF5

NAV (Direct-Growth)

₹10.9730

Last 1Y

+10.19%

Dec 25Min ₹9.10 · Max ₹10.97 · 146 ptsJul 26

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

4

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

  • Expense ratio

    0.74% — typical for category.

  • AUM size

    ₹311 Cr.

  • Sector concentration

    Top 3 sectors = 95.9% — heavy concentration risk.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

PeriodReturnsCategory avgRank
1W+3.00%+0.29%5/ 18
1M+5.03%+3.93%12/ 18
3M+7.27%+5.61%12/ 18
6M+9.91%+12.10%13/ 18
YTD+10.63%+11.97%13/ 18
1Y+12.11%
2Y+12.10%
3Y+22.73%
5Y+13.72%
7Y+19.14%
10Y+13.62%

Portfolio composition

Asset allocation

  • Equity96.27%
  • Cash3.73%

By market cap

  • Large cap41.87%
  • Mid cap22.33%
  • Others35.80%

Concentration

Holdings

38

Avg market cap

₹58.5K Cr

Top 10 stocks

59.05%

Top 5 stocks

39.30%

Top 3 sectors

95.87%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight
  • 1

    Sun Pharmaceuticals Industries Ltd

    9.65%
  • 1

    Sun Pharmaceuticals Industries Ltd

    9.34%
  • 2

    Apollo Hospitals Enterprise Ltd

    8.97%
  • 2

    Apollo Hospitals Enterprise Ltd

    8.67%
  • 3

    Divi's Laboratories Ltd

    7.61%
  • 3

    Divi's Laboratories Ltd

    7.40%
  • 4

    Max Healthcare Institute Ltd Ordinary Shares

    7.14%
  • 5

    Dr Reddy's Laboratories Ltd

    7.12%
  • 4

    Max Healthcare Institute Ltd Ordinary Shares

    6.92%
  • 5

    Cipla Ltd

    6.76%
  • 6

    Cipla Ltd

    6.72%
  • 6

    Dr Reddy's Laboratories Ltd

    5.92%
  • 7

    J.B. Chemicals & Pharmaceuticals Ltd

    4.91%
  • 7

    J.B. Chemicals & Pharmaceuticals Ltd

    4.57%
  • 8

    Triparty Repo Trp_040526

    4.35%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff
  • P/E ratio38.9641.09-2.13
  • P/B ratio5.525.83-0.31
  • Price / Sales5.405.71-0.31
  • Price / Cash Flow29.7230.54-0.82
  • Dividend yield0.78%0.63%+0.15
  • Return on equity (ROE)16.42%16.57%-0.15

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y
  • Standard deviation

    Volatility — lower means steadier returns.

    14.9216.2915.44
  • Sharpe ratio

    Risk-adjusted return — higher is better.

    0.480.980.58
  • Sortino ratio

    Like Sharpe but only counts downside volatility.

    0.831.710.94
  • Beta

    1 = moves with the market. <1 = less volatile.

    0.940.950.94

Peers in Sectoral / Thematic

Other schemes in the same SEBI category, ranked by AUM.

Available plans & options

PlanOptionFull nameISIN

Click a plan to see its NAV and chart above. Direct plans have lower expense ratios than Regular — same portfolio, more of the return stays with you.